Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US House Freshman Democrat Houlahan Explains Why She’s Pro-ACA, But Anti-Device Tax

Executive Summary

Most US House of Representatives Democrats in prior sessions of Congress have been lukewarm in their opposition to the medical device tax, and in the 2018 session, a minority of Democrats voted for repeal. But this year, a large influx of first-term Democratic House members say they campaigned in favor of the Affordable Care Act, which the device tax was designed to support. One of those incoming freshmen, Rep. Chrissy Houlahan, D-Pa., explained to Medtech Insight in a recent interview why she is a staunch supporter of the ACA, but opposes the device tax, and would abolish it.

You may also be interested in...



AdvaMed Pins Hopes For Device Tax Repeal On 10 Senate Democrats, But Could Lose House Support

A coalition of 27 Senators – including 10 Democrats led by Amy Klobuchar, D-Minn. – on March 7 co-sponsored a bill to permanently repeal the device tax. AdvaMed says support of additional Democrats on this year’s bill should persuade Senate leaders to bring S. 692 to the floor for a vote, or it could be attached to other, "must pass"’ legislation. But the bill’s approval in the Democratic-controlled House is uncertain. Sixty-five of 283 “yes,” voters – mostly GOP – favoring tax repeal in the last session, are no longer in office.

Diagnostics Development For Coronavirus Begins As Second US Patient Tests Positive

Bioresearchers at the Centers for Disease Control and Prevention are hoping that diagnostic platforms previously used to develop tests for outbreaks of other epidemic respiratory diseases, including SARS and MERS, can be built on to develop new diagnostics to detect more cases in the current coronavirus outbreak, US infectious disease authorities say. This comes as more patients are monitored around the US for the disease, and a Chicago woman returning from China tests positive.

FDA ‘Stands Ready’ To Fight Coronavirus Via Emergency-Use Test Kits While WHO Mulls Virus Spread, Gets Out Guidance

The US Food and Drug Administration (FDA) stands poised to proceed with hastened approvals for 2019-coronavirus (nCoV) diagnostics, treatments and vaccines, if a public health emergency is declared, after an infected US traveler who caught the disease in Wuhan, China returned from the province to Washington State. Spread of the disease has reached a crisis level in China, and the World Health Organization met on 22 and 23 January to consider what actions to take to contain the virus, while issuing an interim laboratory test guidance for use in diagnosing the disease.

Topics

UsernamePublicRestriction

Register

MT124897

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel